Item 5. Market for Registrant’s Common Equity
Item 5.
Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Our common stock has
been traded on the Nasdaq Stock Market under the symbol “AUUD” since our IPO on February 17, 2021. Our Series A Warrants have
been traded on the Nasdaq Stock Market under the symbol “AUUDW” since our IPO on February 17, 2021. As of March 10, 2023,
there were approximately 138 holders of record of our common stock and 1 holder of record of our Series A warrants. These numbers are
based on the actual number of holders registered at such date and does not include holders whose shares are held in “street name”
by brokers and other nominees.
Dividends
We have never paid any cash
dividends on our common stock. We currently intend to retain all available funds and any future earnings for use in the operation of our
business and do not anticipate paying any cash dividends on our common stock in the foreseeable future. Any future determination to declare
dividends will be made at the discretion of our board of directors and will depend on our financial condition, operating results, capital
requirements, general business conditions and other factors that our board of directors may deem relevant.
Recent Sales of Unregistered Securities
During the year ended December 31, 2022, all sales
of unregistered securities by the Company have been previously reported on a Form 8-K or Form 10-Q.
Use of Proceeds
On February 16, 2021, the U.S. Securities and Exchange
Commission declared effective our registration statement on Form S-1 (File No. 333-235891), as amended, filed in connection with our IPO.
There has been no material change in the planned use of proceeds from our IPO from that described in the related prospectus dated February
16, 2021, filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act. As described in such IPO prospectus, we have used IPO
proceeds to reduce our bank debt by $4.0 million, to fund a $2.0 million cash reserve to serve as collateral for our remaining $2.0 million
of bank debt that replaced collateral previously provided by a related party, to pay down a significant percentage of our accounts payable
as of December 31, 2020, and to pay deferred compensation owed to a related party.
In July 2021, certain holders of our publicly traded
Series A Warrants exercised approximately 1.1 million warrants for approximately 1.1 million shares of common stock at the cash exercise
price of $4.5375 per share and as a result, we received additional cash proceeds of approximately $5.0 million. In addition, we paid the
remaining $2.0 million, out of our restricted cash, to pay off and terminate our line of credit.
Issuer Purchases of Equity Securities
We did not repurchase any of our equity securities during the period covered
by this Annual Report.
Item 6.
[Reserved]
29
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.